Skip to main content
Contact Us
Subscribe
E-Edition
48°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Tango Therapeutics, Inc.
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
November 06, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program
November 06, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics to Participate in Upcoming Investor Conferences
August 28, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
August 07, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
May 08, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
March 18, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics to Participate in Upcoming Investor Conferences
March 06, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Announces Presentation of Preclinical Data on Lead Program and Discovery Platform in Five Abstracts Accepted at AACR-NCI-EORTC 2021
September 30, 2021
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.